Issues & Advocacy

SNMMI's mission with regard to health policy and regulatory affairs is to enhance its credibility, advance its issues, and through leadership become a valued partner among public policy stakeholders.

LATEST NEWS

  • December 10, 2014Looking Ahead: 114th Congress
    Following Senator Mary Landrieu’s (D-LA) defeat to Rep. Bill Cassidy (R-LA) on December 6, Republicans now hold a 54-46 majority in the Senate. Republicans also retained control of the House of Representatives with a 244-188 majority.
  • December 8, 2014Election 2014: GOP Wins a Majority in the Senate
    Following the November 4 midterm elections, Republicans have gained a majority in the Senate. This gives control of the Senate to the Republicans for the first time since 2006.
  • November 21, 2014SNMMI Comments on NRC Part 35 and Part 20 Rules
    The Society recently submitted comments on NRC 10 CFR Part 35 and Part 20.
  • October 31, 2014CMS Releases CY 2015 HOPPS & MPFS Final Rules
    On October 31, CMS released the CY 2015 Final Rules for the Hospital Outpatient Prospective Payment System (HOPPS) and the Medicare Physician Fee Schedule.
  • October 30, 2014Highlights of SNMMI’s FDA Stakeholder Meeting
    On October 27, 2014, SNMMI hosted a broad stakeholder meeting in Linthicum Heights, Md. The society brought in more than 40 experts from the field of nuclear medicine and molecular imaging to discuss the current regulatory climate.
  • October 17, 2014SNMMI Submits Comments to TJC
    On October 17, SNMMI submitted comments to The Joint Committee (TJC) regarding proposed revisions to diagnostic imaging services.
  • October 13, 2014Mallinckrodt to Increase Prices
    Mallinckrodt informed customers that, due to some of the significant cost drivers that the nuclear medicine industry is experiencing, they will be increasing prices over the next several years.
  • October 6, 2014Upcoming Freeze on Claims for FDG PET for Solid Tumors
    CMS has announced a temporary processing freeze on claims submitted for FDG PET for Solid Tumors between October 6 and November 10.

  • Click For More Government Relations News